lg 100268 has been researched along with Urinary Bladder Neoplasms in 1 studies
LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Troglitazone treatment increased expression of two cyclin-dependent kinase inhibitors, p21(WAF1/CIP1) and p16(INK4), and reduced cyclin D1 expression, consistent with G1 arrest." | 1.30 | Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death. ( Breyer, MD; Breyer, RM; Davis, L; Guan, YF; Zhang, YH, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, YF | 1 |
| Zhang, YH | 1 |
| Breyer, RM | 1 |
| Davis, L | 1 |
| Breyer, MD | 1 |
1 other study available for lg 100268 and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Carcinoma, Transitional Cell; Carrier Proteins; Cell | 1999 |